135 (Nimodipine 30 mg)
Pill with imprint 135 is Yellow, Capsule-shape and has been identified as Nimodipine 30 mg. It is supplied by Caraco Pharmaceutical Laboratories.
Nimodipine is used in the treatment of subarachnoid hemorrhage and belongs to the drug class calcium channel blocking agents. Risk cannot be ruled out during pregnancy. Nimodipine 30 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 135
Nimodipine
- Imprint
- 135
- Strength
- 30 mg
- Color
- Yellow
- Size
- 20.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Calcium channel blocking agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Caraco Pharmaceutical Laboratories
- National Drug Code (NDC)
- 57664-0135
- Inactive Ingredients
-
glycerin,
peppermint oil,
water,
polyethylene glycol,
gelatin,
D&C Yellow No. 10,
titanium dioxide,
ammonia,
ferrosoferric oxide,
butyl alcohol,
isopropyl alcohol,
shellac,
alcohol,
propylene glycol,
medium-chain triglycerides
Note: Inactive ingredients may vary.
Related Images for "135"
More about nimodipine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 3 Reviews
- Drug class: calcium channel blocking agents
- FDA Alerts (2)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.